Does inhibition of glycogen synthase kinase protect in mice?
作者信息
Murphy Elizabeth, Steenbergen Charles
机构信息
Vascular Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA.
出版信息
Circ Res. 2008 Aug 1;103(3):226-8. doi: 10.1161/CIRCRESAHA.108.181602.
Abstract
摘要
相似文献
1
Does inhibition of glycogen synthase kinase protect in mice?
Circ Res. 2008 Aug 1;103(3):226-8. doi: 10.1161/CIRCRESAHA.108.181602.
2
Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Dis Model Mech. 2015 Aug 1;8(8):931-40. doi: 10.1242/dmm.020511. Epub 2015 Jun 18.
3
Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition.
Anesth Analg. 2008 Sep;107(3):769-75. doi: 10.1213/ane.0b013e3181815b84.
4
Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β.
Oxid Med Cell Longev. 2013;2013:306421. doi: 10.1155/2013/306421. Epub 2013 Dec 18.
5
Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):278-84. doi: 10.1016/s1499-3872(12)60161-1.
6
Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Ann Thorac Surg. 2007 Jul;84(1):126-33. doi: 10.1016/j.athoracsur.2007.02.015.
7
Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.
Pharmacol Ther. 2014 Jan;141(1):1-12. doi: 10.1016/j.pharmthera.2013.07.010. Epub 2013 Jul 31.
8
Inhibition of glycogen synthase kinase-3β prevents activation of focal adhesion kinase after ischemia/reperfusion of the rat lung.
Clin Hemorheol Microcirc. 2010;46(2-3):169-81. doi: 10.3233/CH-2010-1343.
9
Invited commentary.
Ann Thorac Surg. 2007 Jul;84(1):133. doi: 10.1016/j.athoracsur.2007.02.046.
10
Inhibition of glycogen synthase kinase enhances isoflurane-induced protection against myocardial infarction during early reperfusion in vivo.
Anesth Analg. 2006 May;102(5):1348-54. doi: 10.1213/01.ane.0000202379.61338.37.
引用本文的文献
1
Mitochondrial Kinase Signaling for Cardioprotection.
Int J Mol Sci. 2024 Apr 19;25(8):4491. doi: 10.3390/ijms25084491.
2
GSK3β Inhibition Is the Molecular Pivot That Underlies the Mir-210-Induced Attenuation of Intrinsic Apoptosis Cascade during Hypoxia.
Int J Mol Sci. 2022 Aug 19;23(16):9375. doi: 10.3390/ijms23169375.
3
Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential.
PLoS One. 2015 Mar 16;10(3):e0119790. doi: 10.1371/journal.pone.0119790. eCollection 2015.
4
The GSK-3 family as therapeutic target for myocardial diseases.
Circ Res. 2015 Jan 2;116(1):138-49. doi: 10.1161/CIRCRESAHA.116.303613.
5
Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.
Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H297-308. doi: 10.1152/ajpheart.00999.2011. Epub 2012 Jun 1.
6
Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism.
Hepatology. 2011 Aug;54(2):687-96. doi: 10.1002/hep.24419. Epub 2011 Jun 26.
7
Targeting GSK-3 family members in the heart: a very sharp double-edged sword.
J Mol Cell Cardiol. 2011 Oct;51(4):607-13. doi: 10.1016/j.yjmcc.2010.11.020. Epub 2010 Dec 13.
8
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.
Physiol Rev. 2010 Oct;90(4):1507-46. doi: 10.1152/physrev.00054.2009.
9
Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells.
Mol Vis. 2010 Apr 9;16:630-8.
10
GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice.
J Clin Invest. 2010 Jul;120(7):2280-91. doi: 10.1172/JCI41407.
本文引用的文献
1
Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse.
Circ Res. 2008 Aug 1;103(3):307-14. doi: 10.1161/CIRCRESAHA.107.169953. Epub 2008 Jun 26.
2
Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
Circulation. 2008 May 27;117(21):2761-8. doi: 10.1161/CIRCULATIONAHA.107.755066. Epub 2008 May 19.
3
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.
Nat Cell Biol. 2007 May;9(5):550-5. doi: 10.1038/ncb1575. Epub 2007 Apr 8.
4
Preconditioning: the mitochondrial connection.
Annu Rev Physiol. 2007;69:51-67. doi: 10.1146/annurev.physiol.69.031905.163645.
5
Inhibition of glycogen synthase kinase enhances isoflurane-induced protection against myocardial infarction during early reperfusion in vivo.
Anesth Analg. 2006 May;102(5):1348-54. doi: 10.1213/01.ane.0000202379.61338.37.
6
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.
J Clin Invest. 2004 Jun;113(11):1535-49. doi: 10.1172/JCI19906.
7
Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
Circ Res. 2004 Apr 16;94(7):960-6. doi: 10.1161/01.RES.0000122392.33172.09. Epub 2004 Feb 19.
8
Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective.
Circ Res. 2002 Mar 8;90(4):377-9. doi: 10.1161/01.res.0000012567.95445.55.
Zotero 插件